Integra LifeSciences launches proposed $600 million senior secured Term Loan B refinancing

By Public Technologies
  • Integra LifeSciences launched a proposed USD 600 million seven-year Senior Secured Term Loan B refinancing.
  • Net proceeds earmarked to refinance certain existing indebtedness, cover related fees, preserve financial flexibility, extend maturities.
  • Completion tied to a broader capital structure refinancing, subject to market conditions; final size, terms, pricing not set.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020800PRIMZONEFULLFEED9838414) on October 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.